Power wheelchair — group 2 denied as not medically necessary by UnitedHealthcare?

Under UnitedHealthcare's Commercial medical policy, mobility devices including manual wheelchairs, electric wheelchairs, transfer chairs, scooters/power-operated vehicles (POV), canes, and walkers are a covered health care service when medically necessary. The policy aligns with CMS LCD L33789, which establishes that the beneficiary must have a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADLs) such as toileting, feeding, dressing, grooming, and bathing in customary locations in the home — a limitation that prevents the beneficiary from accomplishing an MRADL entirely, places the beneficiary at heightened risk of morbidity or mortality, or prevents completing an MRADL within a reasonable time frame ; additionally, the mobility limitation cannot be sufficiently and safely resolved by an appropriately fitted cane or walker, and the beneficiary does not have sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day. Use of a power wheelchair must significantly improve the beneficiary's ability to participate in MRADLs and the beneficiary will use it in the home (for severe cognitive/physical impairments, participation in MRADLs may require caregiver assistance), and the beneficiary has not expressed an unwillingness to use a power wheelchair in the home. For a Group 2 standard PWC, a Group 2 PWC (K0820, K0821, K0822, K0823, K0824, K0825, K0826, K0827, K0828, K0829) is covered if all of the coverage criteria (a)-(e) for a PWC are met and the wheelchair is appropriate for the beneficiary's weight. For a Group 2 Single Power Option PWC, all coverage criteria (a)-(e) must be met, plus the beneficiary meets coverage criteria for a power tilt or recline seating system OR requires a drive control interface other than a hand or chin-operated standard proportional joystick (examples include head control, sip and puff, switch control) , and a specialty evaluation must be performed by a licensed/certified medical professional (PT, OT, or practitioner with rehab wheelchair training) with no financial relationship with the supplier, and the wheelchair must be provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) with direct, in-person involvement in the wheelchair selection. DME has a reasonable useful lifetime (RUL) of 5 years , and payment is made for only one wheelchair at a time; backup chairs are denied as not reasonable and necessary.

- **Document MRADL impact in detail**: Provide a clinician note specifying which MRADLs (toileting, feeding, dressing, grooming, bathing) the patient cannot complete or completes only with heightened morbidity/mortality risk, directly mapping to the LCD L33789 definition of a qualifying mobility limitation . - **Stepwise rule-out of lesser devices**: Submit PT/OT documentation explaining why a cane, walker, and optimally-configured manual wheelchair each fail — addressing strength, endurance, ROM, coordination, pain, or upper-extremity deformity per the LCD's enumerated upper-extremity assessment factors (strength, endurance, range of motion, coordination, pain, deformity or absence of one or both upper extremities) . - **Provide compliant face-to-face and WOPD**: Attach the dated face-to-face mobility examination note and the signed Standard Written Order before delivery; cite Final Rule 1713's requirement of a face-to-face encounter and Written Order Prior to Delivery as satisfied. - **Include RESNA ATP and independent specialty evaluation**: For Group 2 Single Power Option chairs, include both the ATP credential attestation and the independent PT/OT specialty evaluation, satisfying the requirement that a licensed PT/OT with no financial relationship to the supplier perform the specialty evaluation and that a RESNA-certified ATP have direct involvement in wheelchair selection . - **Demonstrate in-home use**: Document home assessment showing adequate access between rooms and maneuvering space, and explicitly state the device will be used in the home to meet the requirement that the beneficiary's home provides adequate access and that the power wheelchair will significantly improve the beneficiary's ability to participate in MRADLs in the home . - **Justify Group 2 over Group 1**: If denied as needing only a Group 1, document the patient's weight against capacity limits or, for Single Power Option, the medical necessity of power tilt/recline (e.g., pressure ulcer risk, inability to perform a functional weight shift) or alternative drive control interface per LCD L33789 Group 2 Single Power Option criteria including need for non-standard drive control such as head control, sip and puff, or switch control . - **Replacement vs. repair**: For replacement requests, document the 5-year RUL and that the existing chair cannot be repaired or no longer meets the patient's needs, citing the 5-year reasonable useful lifetime standard and UHC's allowance for upgrades when the member's condition changes (e.g., impaired function necessitates an upgrade to a power wheelchair from a manual one) .

## UnitedHealthcare Group 2 Power Wheelchair — Medical Necessity Denials

UnitedHealthcare's denial of a Group 2 power wheelchair (HCPCS K0820–K0829) on medical-necessity grounds is almost always traceable to a documentation gap against the seven-factor LCD framework, not a substantive coverage exclusion. UHC's Mobility Devices, Options, and Accessories Commercial and Individual Exchange Medical Policy expressly aligns with CMS LCD L33789, so the analytical framework on appeal is identical to traditional Medicare — even on commercial and exchange plans administered by Optum.

Where UHC reviewers typically cut the chart. The most common failure modes: (1) the face-to-face mobility examination does not articulate why a cane, walker, manual wheelchair, scooter, or Group 1 PWC was each ruled out (the "algorithmic" progression LCD L33789 requires); (2) the specialty evaluation by a PT/OT or physician with rehab training is missing, undated, or performed by a clinician with a financial relationship to the supplier (a non-waivable disqualifier under the policy); (3) the supplier did not document direct, in-person ATP involvement in chair selection; or (4) the MRADL narrative is generic — "patient has difficulty ambulating" — rather than tied to specific in-home activities (toileting, feeding, dressing, grooming, bathing) the beneficiary cannot complete, cannot complete safely, or cannot complete in a reasonable timeframe.

Group 2 Single Power Option (K0835–K0843) adds two more failure points. Reviewers must see either (a) clinical justification for power tilt/recline (pressure injury risk, orthostatic hypotension, contracture management) or (b) inability to operate a standard proportional joystick necessitating head, sip-and-puff, or switch control.

The procedural lever. UHC Commercial DME appeals route through Optum's Clinical Services group, not the medical plan's standard utilization-management queue — confirm the appeal address on the denial letter and submit through the DME-specific fax/portal. Under 29 CFR §2560.503-1(g)–(h), the denial must identify the specific LCD criterion not met and provide free copies of the internal clinical rationale and reviewer credentials on request; demand both. For self-funded ERISA plans, Pinto v. Aetna Life Ins. Co. (10th Cir. 2014) places the burden on UHC to show the chair is not medically necessary once the treating clinician and ATP have substantively documented MRADL impairment — a point worth quoting in the appeal letter. For Medicare Advantage members, 42 CFR §422.566 governs reconsideration timelines and the LCD itself is binding on the MA plan.

Closing tactical tip. Submit the appeal as a paginated packet with a one-page LCD-criterion crosswalk on top: criterion (a) through (e) plus the Single Power Option triggers, each citing the page and line of the underlying chart note. Reviewers approve what they can verify in under five minutes. Include a signed ATP attestation of in-person evaluation, a clinician conflict-of-interest disclosure, and a home-assessment confirming maneuverability (turning radius, doorway widths, threshold heights) — UHC denials silently presume the chair won't be usable in the home unless the record affirmatively rebuts that.